Recent News
Powered by Alpha Vantage
No recent news found.
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot
Abpro Holdings, Inc., a biotechnology company, focuses on novel antibody constructs for immuno-oncology and ophthalmology. The company is headquartered in Woburn, Massachusetts.
52W High
$13.00
52W Low
$0.16
MA Status:
50D: Below
200D: Below
Beta (~1 neutral, <0.9 lower risk)
0.03
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
N/A
EV/Revenue (<3 favorable)
74.79
P/S (TTM) (<3 favorable)
73.64
P/B (<3 favorable)
N/A
Ownership
Retail‑heavySource: Overview
Insiders (1–5% typical)
16.15%
Institutions (25–75% balanced)
1.93%
Shares Outstanding
80,167,000
Float
49,487,700
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
As of 2025-06-30 (Overview)
Revenue (TTM)
183,000
Gross Profit (TTM)
1,300,000
EPS (TTM)
-0.34
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
-54.21%
ROE (TTM) (>15% strong)
N/A
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
-1.00
Momentum
Bearish momentumValue
-0.0240
Previous
-0.0227
Trend
Falling
Signal Cross
No cross
As of
Sep. 12, 2025